{"id":"W4403058047","doi":"10.1055/s-0044-1789693","title":"Efficacy of mirikizumab in patients with moderate-to-severe Crohn’s disease in comparison to ustekinumab: Summary results from the double-blind Phase 3 VIVID-1 trial","year":2024,"lang":"en","type":"article","venue":"Zeitschrift für Gastroenterologie","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"","keywords":"Ustekinumab; Crohn's disease; Double blind; Medicine; Internal medicine; Phase (matter); Disease; Dermatology; Placebo; Pathology; Physics; Alternative medicine; Infliximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000333755,0.0003845385,0.0003956785,0.0001849909,0.00005636183,0.00009330089,0.0005922111,0.0001421174,0.00001565759],"category_scores_gemma":[0.0002764324,0.0002857424,0.0001419527,0.0002423886,0.0001003197,0.00002313856,0.000357183,0.0002956357,0.00002441909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003157952,"about_ca_system_score_gemma":0.0002464786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001391698,"about_ca_topic_score_gemma":0.0009040327,"domain_scores_codex":[0.9970289,0.0002671054,0.0008022019,0.000912861,0.0003781961,0.0006107193],"domain_scores_gemma":[0.9984884,0.00008832086,0.0001295408,0.0008672329,0.0001030392,0.0003234504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8762002,0.001379784,0.1051233,0.0000310837,0.0001015544,0.0002542602,0.0002560302,0.01277221,0.0003073459,0.000009032722,0.003103247,0.000461923],"study_design_scores_gemma":[0.2291884,0.001907349,0.7657359,0.0002533822,0.00007110796,3.128978e-7,0.00004333929,0.0005041964,0.0003899986,0.000003059072,0.001648654,0.0002542748],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995078,0.0001012156,0.0001907368,0.0005048088,0.0003227362,0.002494812,0.001181541,0.00003400011,0.00009220977],"genre_scores_gemma":[0.9976987,0.00000632775,0.0001677965,0.0005118267,0.0001845318,0.0001951455,0.001151534,0.00005046717,0.00003368474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6606126,"threshold_uncertainty_score":0.9999595,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0258404374694007,"score_gpt":0.3115402854947364,"score_spread":0.2856998480253357,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}